Provided by Tiger Trade Technology Pte. Ltd.

Biomarin Pharmaceutical

64.67
-0.6250-0.96%
Post-market: 64.670.00000.00%19:30 EDT
Volume:1.10M
Turnover:70.79M
Market Cap:12.50B
PE:170.63
High:65.08
Open:64.99
Low:64.07
Close:65.29
52wk High:70.98
52wk Low:49.26
Shares:193.27M
Float Shares:192.12M
Volume Ratio:0.66
T/O Rate:0.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3790
EPS(LYR):1.80
ROE:1.18%
ROA:3.26%
PB:1.98
PE(LYR):35.93

Loading ...

Apr 03, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 13, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 10, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Feb 27, 2023

Major Issues Report

8-K - Current report
Feb 27, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2023

Major Issues Report

8-K - Current report
Dec 21, 2022

Major Issues Report

8-K - Current report
Oct 28, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 26, 2022

Major Issues Report

8-K - Current report
Oct 07, 2022

Major Issues Report

8-K - Current report
Sep 12, 2022

Major Issues Report

8-K - Current report
Aug 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 03, 2022

Major Issues Report

8-K - Current report
May 31, 2022

Major Issues Report

8-K - Current report
May 05, 2022

Major Issues Report

8-K - Current report
Apr 29, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]